{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:12:03Z","timestamp":1785564723455,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtha.2023.12.024","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T02:29:30Z","timestamp":1703903370000},"page":"965-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype"],"prefix":"10.1016","volume":"22","author":[{"given":"Joseph","family":"Noye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Beggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.12.024_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-016-0242-9","article-title":"Study Alliance Leukemia (SAL). Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry","volume":"9","author":"Kaifie","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.jtha.2023.12.024_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","article-title":"Diagnosis and treatment of acquired von Willebrand syndrome","volume":"130","author":"Tiede","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.12.024_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602969900500301","article-title":"Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia","volume":"5","author":"Michiels","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.12.024_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2007-996119","article-title":"Acquired von Willebrand disease in patients with high platelet counts","volume":"23","author":"Budde","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.12.024_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/rth2.12315","article-title":"Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia","volume":"4","author":"Sacco","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.024_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.12.024_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00277-017-3040-8","article-title":"Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden","volume":"96","author":"Bertozzi","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2023.12.024_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"Rottenstreich","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2023.12.024_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.20452\/pamw.3211","article-title":"Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients","volume":"125","author":"Mital","year":"2015","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jtha.2023.12.024_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36472\/msd.v6i7.284","article-title":"Acquired von Willebrand disease in chronic myeloproliferative disorders: a prospective single-center study","volume":"6","author":"Ekinci","year":"2019","journal-title":"Med Sci Discov"},{"key":"10.1016\/j.jtha.2023.12.024_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bjh.15647","article-title":"A\u00a0guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British Society for Haematology Guideline","volume":"184","author":"McMullin","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.12.024_bib13","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.024_bib14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.024_bib15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.024_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.12.024_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ajh.25393","article-title":"Automated assays for von Willebrand factor activity","volume":"94","author":"Higgins","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.12.024_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ejh.13721","article-title":"Bleeding complications in bcr-abl-negative myeloproliferative neoplasms (MPN): a retrospective single-center study of 829 MPN patients","volume":"108","author":"Wille","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2023.12.024_bib19","first-page":"264","article-title":"Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution","volume":"87","author":"S\u00e1nchez-Luceros","year":"2002","journal-title":"Haematologica"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:08:26Z","timestamp":1744452506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623009261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1538783623009261"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}